What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Mutation
Jerry R. Mendell focuses on Internal medicine, Muscular dystrophy, Pathology, Duchenne muscular dystrophy and Endocrinology.
His Internal medicine study incorporates themes from Gastroenterology, Surgery and Periodic paralysis.
Jerry R. Mendell interconnects Limb-girdle muscular dystrophy, Anticipation, Clinical trial and Immunology in the investigation of issues within Muscular dystrophy.
The Pathology study combines topics in areas such as Peripheral neuropathy, Central nervous system and Anatomy, Nerve fiber.
His Dystrophin and Duchenne dystrophy study, which is part of a larger body of work in Duchenne muscular dystrophy, is frequently linked to Eteplirsen, bridging the gap between disciplines.
His Endocrinology research focuses on Muscle disorder and how it relates to Transgene.
His most cited work include:
- Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model (1437 citations)
- Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model (1437 citations)
- Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy (758 citations)
What are the main themes of his work throughout his whole career to date?
Jerry R. Mendell mainly focuses on Duchenne muscular dystrophy, Muscular dystrophy, Internal medicine, Dystrophin and Pathology.
His research on Duchenne muscular dystrophy also deals with topics like
- Bioinformatics and related Genetic enhancement,
- Clinical trial most often made with reference to Physical therapy.
He combines subjects such as Limb-girdle muscular dystrophy, Dystrophy, Gene and Skeletal muscle with his study of Muscular dystrophy.
His study on Internal medicine also encompasses disciplines like
- Endocrinology which intersects with area such as Gene delivery,
- Surgery, which have a strong connection to Placebo and Anesthesia.
He frequently studies issues relating to Immunology and Dystrophin.
His Pathology study often links to related topics such as Anatomy.
He most often published in these fields:
- Duchenne muscular dystrophy (35.90%)
- Muscular dystrophy (32.05%)
- Internal medicine (29.01%)
What were the highlights of his more recent work (between 2015-2021)?
- Duchenne muscular dystrophy (35.90%)
- Clinical trial (15.21%)
- Internal medicine (29.01%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Duchenne muscular dystrophy, Clinical trial, Internal medicine, Muscular dystrophy and Spinal muscular atrophy.
He works on Duchenne muscular dystrophy which deals in particular with Dystrophin.
Jerry R. Mendell has included themes like Endocrinology, Genetic enhancement and Cardiology in his Internal medicine study.
As a part of the same scientific study, he usually deals with the Endocrinology, concentrating on Gene delivery and frequently concerns with Gastrocnemius muscle.
His work deals with themes such as Fibrosis, Vector, Adeno-associated virus and Skeletal muscle, which intersect with Muscular dystrophy.
His research integrates issues of Gene replacement therapy, Anesthesia, Motor neuron and Phases of clinical research in his study of Spinal muscular atrophy.
Between 2015 and 2021, his most popular works were:
- Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy (758 citations)
- Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy. (273 citations)
- Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy (81 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Disease
Jerry R. Mendell spends much of his time researching Duchenne muscular dystrophy, Muscular dystrophy, Internal medicine, Genetic enhancement and Eteplirsen.
His work in the fields of Dystrophin overlaps with other areas such as Vital capacity.
Jerry R. Mendell focuses mostly in the field of Dystrophin, narrowing it down to matters related to Cancer research and, in some cases, Utrophin, Gene silencing and Morpholino.
The Muscular dystrophy study combines topics in areas such as Limb-girdle muscular dystrophy, Gene and Skeletal muscle.
His Internal medicine study frequently links to adjacent areas such as Dysphagia.
His Genetic enhancement research integrates issues from Endocrinology, Clinical trial, Bioinformatics, Dystrophy and Fibrosis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
